# Panc CA Risk Model & Biomarker Testing In High-Risk Cohort

> **NCT05287347** · — · WITHDRAWN · sponsor: **Beth Israel Deaconess Medical Center**

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Blood Specimen

## Key facts

- **NCT ID:** NCT05287347
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-12-03
- **Final completion:** 2024-12-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2025-05-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287347, "Panc CA Risk Model & Biomarker Testing In High-Risk Cohort". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05287347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*